Concise review: Stem cell therapies for amyotrophic lateral sclerosis: Recent advances and prospects for the future

71Citations
Citations of this article
151Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Amyotrophic lateral sclerosis (ALS) is a lethal disease involving the loss of motor neurons. Although the mechanisms responsible for motor neuron degeneration in ALS remain elusive, the development of stem cell-based therapies for the treatment of ALS has gained widespread support. Here, we review the types of stem cells being considered for therapeutic applications in ALS, and emphasize recent preclinical advances that provide supportive rationale for clinical translation. We also discuss early trials from around the world translating cellular therapies to ALS patients, and offer important considerations for future clinical trial design. Although clinical translation is still in its infancy, and additional insight into the mechanisms underlying therapeutic efficacy and the establishment of long-term safety are required, these studies represent an important first step toward the development of effective cellular therapies for the treatment of ALS. © 2014 AlphaMed Press.

Cite

CITATION STYLE

APA

Lunn, J. S., Sakowski, S. A., & Feldman, E. L. (2014). Concise review: Stem cell therapies for amyotrophic lateral sclerosis: Recent advances and prospects for the future. Stem Cells. Wiley-Blackwell. https://doi.org/10.1002/stem.1628

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free